This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This is an erythromycin derivative with greater activity.


  • respiratory tract infections
  • skin and soft tissue infections


  • hepatic impairment
  • reduced dose in renal impairment


  • diarrhoea
  • cholestatic jaundice if give for more than 14 days
  • nausea and vomiting

Routes of administration:

  • oral; þ tablets

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.